GORMAN KEVIN CHARLES sold NBIX
September 11, 2026 · Form 4 insider transaction
GORMAN KEVIN CHARLES sold 7,839 shares of Neurocrine Biosciences, Inc. at $156.22 per share, a transaction worth $1.22M. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
7,839
Price
$156.22
Total value
$1.22M
InsiderGORMAN KEVIN CHARLES
Role—
SecurityCommon Stock
Transaction codeF: Shares withheld for taxes
Transaction dateSeptember 11, 2026
Filing dateSeptember 15, 2026
Shares owned after517,797
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Shares withheld by Neurocrine Biosciences, Inc. (the "Company" or "Issuer") to satisfy tax withholding requirements on vesting of PRSUs. No shares were sold.; 517,797 of the outstanding shares are held by the Gorman and Blais Family Trust, of which Dr. Gorman has voting and investment power.